全文获取类型
收费全文 | 510篇 |
免费 | 33篇 |
国内免费 | 1篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 3篇 |
妇产科学 | 4篇 |
基础医学 | 21篇 |
口腔科学 | 9篇 |
临床医学 | 40篇 |
内科学 | 122篇 |
皮肤病学 | 3篇 |
神经病学 | 15篇 |
特种医学 | 2篇 |
外科学 | 212篇 |
综合类 | 3篇 |
预防医学 | 67篇 |
眼科学 | 5篇 |
药学 | 25篇 |
肿瘤学 | 8篇 |
出版年
2024年 | 1篇 |
2023年 | 2篇 |
2022年 | 3篇 |
2021年 | 31篇 |
2020年 | 12篇 |
2019年 | 16篇 |
2018年 | 38篇 |
2017年 | 20篇 |
2016年 | 13篇 |
2015年 | 13篇 |
2014年 | 31篇 |
2013年 | 42篇 |
2012年 | 56篇 |
2011年 | 52篇 |
2010年 | 28篇 |
2009年 | 19篇 |
2008年 | 38篇 |
2007年 | 39篇 |
2006年 | 14篇 |
2005年 | 29篇 |
2004年 | 17篇 |
2003年 | 7篇 |
2002年 | 6篇 |
2001年 | 5篇 |
1999年 | 3篇 |
1997年 | 2篇 |
1996年 | 1篇 |
1992年 | 1篇 |
1990年 | 1篇 |
1986年 | 1篇 |
1977年 | 1篇 |
1975年 | 1篇 |
1974年 | 1篇 |
排序方式: 共有544条查询结果,搜索用时 15 毫秒
1.
2.
3.
Balwinder Singh Anastasia K. Yocum Rebecca Strawbridge Katherine E. Burdick Caitlin E. Millett Amy T. Peters Sarah H. Sperry Giovanna Fico Eduard Vieta Norma Verdolini Ophelia Godin Marion Leboyer Bruno Etain Ivy F. Tso Brandon J. Coombes Melvin G. McInnis Andrew A. Nierenberg Allan H. Young Melanie M. Ashton Michael Berk Lana J. Williams Kamyar Keramatian Lakshmi N. Yatham Bronwyn J. Overs Janice M. Fullerton Gloria Roberts Philip B. Mitchell Ole A. Andreassen Ana C. Andreazza Peter P. Zandi Daniel Pham Joanna M. Biernacka Mark A. Frye The FACE-BD Collaborators The Global Bipolar Cohort Collaborative 《Bipolar disorders》2024,26(1):22-32
4.
5.
6.
Kamyar Kalantar-Zadeh Philip Kam-Tao Li Ekamol Tantisattamo Latha Kumaraswami Vassilios Liakopoulos Siu-Fai Lui Ifeoma Ulasi Sharon Andreoli Alessandro Balducci Sophie Dupuis Tess Harris Anne Hradsky Richard Knight Sajay Kumar Maggie Ng Alice Poidevin Gamal Saadi Allison Tong 《Nefrología : publicación oficial de la Sociedad Espa?ola Nefrologia》2021,41(2):95-101
Living with chronic kidney disease (CKD) is associated with hardships for patients and their care-partners. Empowering patients and their care-partners, including family members or friends involved in their care, may help minimize the burden and consequences of CKD related symptoms to enable life participation. There is a need to broaden the focus on living well with kidney disease and re-engagement in life, including an emphasis on patients being in control. The World Kidney Day (WKD) Joint Steering Committee has declared 2021 the year of “Living Well with Kidney Disease” in an effort to increase education and awareness on the important goal of patient empowerment and life participation. This calls for the development and implementation of validated patient-reported outcome measures to assess and address areas of life participation in routine care. It could be supported by regulatory agencies as a metric for quality care or to support labelling claims for medicines and devices. Funding agencies could establish targeted calls for research that address the priorities of patients. Patients with kidney disease and their care-partners should feel supported to live well through concerted efforts by kidney care communities including during pandemics. In the overall wellness programme for kidney disease patients, the need for prevention should be reiterated. Early detection with a prolonged course of wellness despite kidney disease, after effective secondary and tertiary prevention programmes, should be promoted. WKD 2021 continues to call for increased awareness of the importance of preventive measures throughout populations, professionals, and policy makers, applicable to both developed and developing countries. 相似文献
7.
Melissa Soohoo Elani Streja Yoshitsugu Obi Connie M. Rhee Daniel L. Gillen Keiichi Sumida Danh V. Nguyen Csaba P. Kovesdy Kamyar Kalantar-Zadeh 《Mayo Clinic proceedings. Mayo Clinic》2018,93(8):1074-1085
Objective
To determine whether kidney function level and its rate of decline in the immediate predialysis period among veterans transitioning to end-stage renal disease (ESRD) predict postdialysis mortality and hospitalization.Patients and Methods
In 19,985 veterans transitioning to ESRD during the period October 1, 2007, to March 30, 2014, we examined kidney function and its slope over the final year of the pre-ESRD(prelude) period. Two categories of low vs high estimated glomerular filtration rate (eGFR, dichotomized at 10 mL/min/1.73 m2) and slow vs fast slope (dichotomized at ?10 mL/min/1.73 m2/y) were combined into 4 groups. Their associations with 12-month post-ESRD all-cause and cardiovascular (CV) mortality and hospitalization rates were examined in adjusted models accounting for clinical characteristics and laboratory measurements at transition.Results
Patients, 66±11 years old, and 34% blacks, had a median (interquartile range) eGFR at transition and slope of 9.7 (7.1-13.3) mL/min/1.73 m2 and ?10.5 (?18.8 to ?5.9) mL/min/1.73 m2/y, respectively. Patients with a low eGFR and slow slope had the lowest 12-month all-cause and CV mortality risks and hospitalization rate. Conversely, patients with high eGFR and fast slope had the highest risk of all-cause and CV mortality and hospitalization rate compared with patients with a low eGFR and slow slope. This relationship persisted in sensitivity analyses, including propensity scoring.Conclusion
A kidney profile of a low eGFR and slow slope in the prelude period is associated with favorable early dialysis outcomes in veteran patients. Trials to examine a more conservative approach to dialysis are warranted. 相似文献8.
John J. Sim MD Jiaxiao Shi PhD Rushdy Al‐Moomen MD Hind Behayaa MS Kamyar Kalantar‐Zadeh MD PhD Steven J. Jacobsen MD PhD 《Journal of clinical hypertension (Greenwich, Conn.)》2014,16(11):805-813
Plasma renin activity (PRA) may be a surrogate for vascular damage. The authors hypothesize that PRA is associated with cardiovascular and cerebrovascular disease (CED). A cross‐sectional study (January 1, 1998, to December 31, 2009) was performed on hypertensive individuals 18 years and older using multivariable logistic regression models to estimate odds ratios (ORs) for ischemic heart disease (IHD), congestive heart failure (CHF), and CED based on PRA quartiles controlling for age, sex, race, diabetes mellitus (DM), and medication use. Among 7887 individuals (60% women; 34% whites, 23% blacks, and 19% Hispanics; and 29% with DM), the adjusted ORs (95% CI) for IHD were 0.94 (0.80–1.10), 1.09 (0.92–1.29), and 1.18 (1.00–1.39); for CHF were 1.23 (0.99–1.53), 1.27 (1.01–1.61), and 1.41 (1.13–1.77); and for CED were 0.95 (0.78–1.17), 0.77 (0.61–0.97), and 0.97 (0.78–1.20) for the second, third, and fourth quartiles compared with the first quartile. Higher PRA was associated with greater likelihood for prevalent IHD and CHF but not CED in this large ethnically diverse population of hypertensive individuals. 相似文献
9.
10.
M Soleimani S Barone J Xu GE Shull F Siddiqui K Zahedi H Amlal 《Proceedings of the National Academy of Sciences of the United States of America》2012,109(33):13368-13373
The Na-Cl cotransporter (NCC), which is the target of inhibition by thiazides, is located in close proximity to the chloride-absorbing transporter pendrin in the kidney distal nephron. Single deletion of pendrin or NCC does not cause salt wasting or excessive diuresis under basal conditions, raising the possibility that these transporters are predominantly active during salt depletion or in response to excess aldosterone. We hypothesized that pendrin and NCC compensate for loss of function of the other under basal conditions, thereby masking the role that each plays in salt absorption. To test our hypothesis, we generated pendrin/NCC double knockout (KO) mice by crossing pendrin KO mice with NCC KO mice. Pendrin/NCC double KO mice displayed severe salt wasting and sharp increase in urine output under basal conditions. As a result, animals developed profound volume depletion, renal failure, and metabolic alkalosis without hypokalemia, which were all corrected with salt replacement. We propose that the combined inhibition of pendrin and NCC can provide a strong diuretic regimen without causing hypokalemia for patients with fluid overload, including patients with congestive heart failure, nephrotic syndrome, diuretic resistance, or generalized edema. 相似文献